313 related articles for article (PubMed ID: 16219644)
1. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis.
Nakamura T; Higashi S; Tomoda K; Tsukano M; Baba S; Shono M
Rheumatology (Oxford); 2006 Jan; 45(1):43-9. PubMed ID: 16219644
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
Nakamura T; Higashi S; Tomoda K; Tsukano M; Shono M
Rheumatology (Oxford); 2012 Nov; 51(11):2064-9. PubMed ID: 22879465
[TBL] [Abstract][Full Text] [Related]
3. Ageing: a risk factor for amyloid A amyloidosis in rheumatoid arthritis.
Okuda Y; Yamada T; Matsuura M; Takasugi K; Goto M
Amyloid; 2011 Sep; 18(3):108-11. PubMed ID: 21627560
[TBL] [Abstract][Full Text] [Related]
4. Influence of Serum Amyloid A (SAA1) and SAA2 gene polymorphisms on renal amyloidosis, and on SAA/C-reactive protein values in patients with familial mediterranean fever in the Turkish population.
Bakkaloglu A; Duzova A; Ozen S; Balci B; Besbas N; Topaloglu R; Ozaltin F; Yilmaz E
J Rheumatol; 2004 Jun; 31(6):1139-42. PubMed ID: 15170927
[TBL] [Abstract][Full Text] [Related]
5. Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis.
Nakamura T
Mod Rheumatol; 2008; 18(2):109-18. PubMed ID: 18369528
[TBL] [Abstract][Full Text] [Related]
6. Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis.
Moriguchi M; Terai C; Koseki Y; Uesato M; Nakajima A; Inada S; Nishinarita M; Uchida S; Nakajima A; Kim SY; Chen CL; Kamatani N
Hum Genet; 1999 Oct; 105(4):360-6. PubMed ID: 10543406
[TBL] [Abstract][Full Text] [Related]
7. Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis.
van der Hilst JC; Yamada T; Op den Camp HJ; van der Meer JW; Drenth JP; Simon A
Rheumatology (Oxford); 2008 Nov; 47(11):1651-4. PubMed ID: 18815155
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis.
Nakamura T; Yamamura Y; Tomoda K; Tsukano M; Shono M; Baba S
Clin Rheumatol; 2003 Dec; 22(6):371-5. PubMed ID: 14677008
[TBL] [Abstract][Full Text] [Related]
9. A novel single-nucleotide polymorphism at the 5'-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis.
Moriguchi M; Terai C; Kaneko H; Koseki Y; Kajiyama H; Uesato M; Inada S; Kamatani N
Arthritis Rheum; 2001 Jun; 44(6):1266-72. PubMed ID: 11407685
[TBL] [Abstract][Full Text] [Related]
10. [Serum amyloid A (SAA) 1, SAA 2 and apolipoprotein E isotype frequencies in rheumatoid arthritis patients with AA amyloidosis].
Okuda Y; Yamada T; Takasugi K; Takeda M; Nanba S; Onishi M; Miyamoto T; Inoue Y
Ryumachi; 1999 Feb; 39(1):3-10. PubMed ID: 10332210
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis.
Nakamura T; Higashi S; Tomoda K; Tsukano M; Baba S
Clin Exp Rheumatol; 2007; 25(4):518-22. PubMed ID: 17888205
[TBL] [Abstract][Full Text] [Related]
12. Variant mannose-binding lectin 2 genotype is a risk factor for reactive systemic amyloidosis in rheumatoid arthritis.
Maury CP; Aittoniemi J; Tiitinen S; Laiho K; Kaarela K; Hurme M
J Intern Med; 2007 Oct; 262(4):466-9. PubMed ID: 17875183
[TBL] [Abstract][Full Text] [Related]
13. Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis.
Uda H; Yokota A; Kobayashi K; Miyake T; Fushimi H; Maeda A; Saiki O
J Rheumatol; 2006 Aug; 33(8):1482-7. PubMed ID: 16881107
[TBL] [Abstract][Full Text] [Related]
14. Genetic risk factors of amyloidogenesis in familial Mediterranean fever.
Delibaş A; Oner A; Balci B; Demircin G; Bulbul M; Bek K; Erdoğan O; Baysun S; Yilmaz E
Am J Nephrol; 2005; 25(5):434-40. PubMed ID: 16118480
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics and genetic background of secondary amyloidosis associated with rheumatoid arthritis in Japanese].
Nakai H; Ozaki S; Kano S; Goto M; Komatsubara Y; Kondo S; Shimizu M; Takasugi K; Hanyu T; Matsuno H; Matsubara T; Yamana S
Ryumachi; 1996 Feb; 36(1):25-33. PubMed ID: 8711535
[TBL] [Abstract][Full Text] [Related]
16. Abdominal fat aspiration biopsy and genotyping of serum amyloid A contribute to early diagnosis of reactive AA amyloidosis secondary to rheumatoid arthritis.
Ishii W; Matsuda M; Nakamura A; Nakamura N; Suzuki A; Ikeda S
Intern Med; 2003 Sep; 42(9):800-5. PubMed ID: 14518665
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the modifying effects of SAA1, SAA2 and TNF-alpha gene polymorphisms on development of amyloidosis in FMF patients.
Yilmaz E; Balci B; Kutlay S; Ozen S; Ertürk S; Oner A; Beşbaş N; Bakkaloğlu A
Turk J Pediatr; 2003; 45(3):198-202. PubMed ID: 14696796
[TBL] [Abstract][Full Text] [Related]
18. [An AA-amyloidosis course in patients with rheumatoid arthritis].
Sarkisova IA; Rameev VV; Varshavskiĭ VA; Golitsyn EP; Kozlovskaia LV
Ter Arkh; 2006; 78(5):31-6. PubMed ID: 16889046
[TBL] [Abstract][Full Text] [Related]
19. SAA1 alleles as risk factors in reactive systemic AA amyloidosis.
Booth DR; Booth SE; Gillmore JD; Hawkins PN; Pepys MB
Amyloid; 1998 Dec; 5(4):262-5. PubMed ID: 10036584
[TBL] [Abstract][Full Text] [Related]
20. [Lethal complications and associated diseases of rheumatoid arthritis--a retrospective clinicopathologic study of 234 autopsy patients].
Bély M; Apáthy A
Orv Hetil; 2006 Jun; 147(23):1063-76. PubMed ID: 16856508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
